The Chediak-Higashi syndrome (CHS) has been reported in man, cattle, mink, and mice. CHS humans and cattle have an increased incidence of pyogenic infections, whereas CHS mink are more susceptible to Aleutian disease. Age-and sex-matched groups of CHS mice (mutant strain) and C57 Bl/6N (parent strain) were challenged with Candida albicans, E.scherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus intravenously and Streptococcus pneumoniae intraperitoneally. A significant increase (P < 0.001) in mortality rate for the CHS mice was demonstrated with all five challenge organisms. Heterozygous mice challenged with C. albicans had a mortality rate essentially the same as C57 Bl/6N mice. The serum immunoglobulin concentrations of CHS mice were found to be the same or greater than the control or heterozygous mice. CHS mice have an increased susceptibility to pyogenic infections, which is not due to immunoglobulin deficiency. These mice may provide a useful laboratory model for the study of increased susceptibility to infection.
The Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disease first described in man in 1943 (1) . A similar syndrome has been described in mink (6) , cattle (8) , and mice (7) . The primary characteristics of this syndrome are pigmentary dilution (partial oculocutaneous albinism), frequent and severe pyogenic infections (man, mink, and cattle), and giant lysosomal granules that can be demonstrated in all granule-containing cells (2) . The fundamental defect which leads to an increased susceptibility to pathogenic microorganisms has not been delineated. However, studies in humans have demonstrated defects in leukocyte regulation, structure, and function that may contribute to increased susceptibility to bacterial infections (12) . Thus far, the responses of CHS mice to challenge with microorganisms have not been reported. Therefore, the following experiments were done to evaluate the susceptibility of CHS mice to infectious agents and to detect a possible impairment of humoral immunity by measuring serum immunoglobulin (Ig) concentrations.
MATERIALS AND METHODS Animals. All mice were bred at the National Institutes of Health, Bethesda, Md. The control mice were C57 Bl/6N (parent strain), and CHS "beige" mice were the mutant strain (bg). These pneumoniae (ATCC 8045) were stored at room temperature on semisolid agar slants and subcultured in Trypticase soy broth at 37 C for 18 h. After the cultures were washed twice with modified Hank solution, the concentration of organisms was estimated by turbidity using a spectrophotometer and diluted to 5 x 107 organisms per 0.2 ml for S. aureus, 2 x 108 organisms per 0.2 ml for E. coli, and 2.5 x 106 organisms per 0.2 ml for K. pneumoniae. Each mouse was injected intravenously with 0.2 ml of the inoculum. The viable number of organisms in the inocula was determined by serial 10-fold dilution and growth on Trypticase soy agar.
Experimental design. For each study, all mice were inoculated with the same concentration of organisms at the same time. Mice were observed at 8-or 12-h intervals and the number of surviving mice was tabulated. Deaths within the first 4 h were considered to be due to technical causes, and these mice were excluded from the study. The study with each microorganism was repeated one or two times with consistent results. The mortality rates were compared statistically for significant differences using the Wilcoxon test (11) .
Ig concentrations. Healthy, uninfected mice were exsanguinated by transection of the axillary artery and vein. The blood was allowed to clot and the serum was separated by centrifugation. All sera were stored at -20 C prior to Ig determination. The IgG1, IgG2, IgA, and IgM concentrations were determined on individual mouse serum samples by radial immunodiffusion (4). The concentrations were expressed as the mean + the standard error of the mean, and groups were compared using the Student's t test.
RESULTS
The CHS mice challenged with C. albicans, S. pneumoniae, K. pneumoniae, S. aureus, and E. coli showed a significant increase (P < 0.001) in mortality rate compared with age-and sexmatched control mice ( Fig. 1-6 (Fig. 1) . With C. albicans, S. pneumoniae, and K. pneumoniae as the challenge organisms, essentially all the mice died; however, the mortality curves for CHS mice were significantly shifted to the left of the control mice. When S. aureus and E. coli were used as the challenge organisms, 78 succumbed, while only 7 and 50% of control mice succumbed, respectively. Therefore, with these two challenge organisms, there was an increase in the total mortality for CHS mice in addition to earlier deaths in these animals.
The results of serum Ig concentrations showed a significant increase (P < 0.001) in serum IgM concentrations of CHS mice compared with the other two groups ( Table 1) . The serum IgA concentrations of CHS mice were significantly greater (P < 0.001) than those of the heterozygous mice. No significant differences between the Ig concentrations of C57 Bl/6N and heterozygous mice were found. DISCUSSION An increased susceptibility to infection has previously been documented in CHS humans, minks, and cattle (9) . This study demonstrates an increased susceptibility of CHS mice to challenge with gram-positive bacteria, gram-negative bacteria, and a fungus. Therefore, all animal species that have been shown to have the CHS as characterized by large lysosomal granules have been shown to have an increased susceptibility to infection.
The mechanism of the increased susceptibility to infection is probably related to impaired cellular function and is not humoral in origin. The serum Ig concentrations of CHS mice were found to be the same or greater than the control or heterozygous mice in this study. These results are consistent with the reported Ig concentrations in CHS in man (2) . Although not measured in mice, antibody production has been reported to be normal in human beings with CHS (2). Therefore, the increased susceptibility to infection in man and mice is not due to serum Ig deficiency. On the other hand, in vitro studies with peripheral blood granulocytes of CHS humans (10) 
